Download PDF
Pharmacopsychiatry 2008; 41(5): 196-199
DOI: 10.1055/s-0028-1082070
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

Gender-dependent Association of a Functional NGF Polymorphism with Anxiety-related Personality Traits

U. E. Lang 1 , R. Hellweg 1 , M. Bajbouj 2 , V. Gaus 3 , T. Sander 4 , J. Gallinat 1
  • 1Clinic for Psychiatry and Psychotherapy, Charité Medicine Berlin, Campus Charité Mitte, Berlin, Germany
  • 2Department of Psychiatry, Charité– Universitaetsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany
  • 3Department of Neurology, Charité Medicine Berlin, Campus Charité Virchow Clinic, Berlin, Germany
  • 4Cologne Center for Genomics, University of Cologne, Cologne, Germany
Further Information

Publication History

received 26.10.2008 revised 07.04.2008

accepted 08.04.2008

Publication Date:
01 September 2008 (online)

Also available at
    Permissions and Reprints

Abstract

Introduction: Nerve growth factor (NGF) has been shown to be involved in anxiety behaviour and the expression of conditioned fear in mice.

Methods: We have tested a total of 337 (age: 39.2 ± 14.6 years) unrelated subjects of German descent (166 males; 171 females) who were carefully screened for psychiatric health. The self-ratable State−Trait Anxiety Inventory, which enables anxiety to be quantified as a comparatively stable personality trait was applied and a recently described non-synonymous NGF SNP (rs6330,c.104C > T,p.Ala35Val) was examined.

Results: In the trait-related anxiety score, a significant gender-dependent effect of the genotype was observed (F=4.580, df=2, p=0.011) with higher levels of trait anxiety in females with C/C genotype when compared to females with T/T and C/T genotypes and an opposite effect in males.

Discussion: Our findings support the hypothesis that anxiety relates to a genetic variation of NGF and that genes modulate behaviour in a gender-dependent manner. Since anxiety and attention deficit hyperactivity disorder are related to NGF, the present results may represent a common biological link for the gender-specific occurrence and comorbidity of the diseases.

References

  • 1 Aloe L, Bracci-Laudiero L, Alleva E, Lambiase A, Micera A, Tirassa P. Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes.  Proc Natl Acad Sci USA. 1994;  91 10440-10444
    CrossrefPubMedGoogle Scholar
  • 2 Altemus M. Sex differences in depression and anxiety disorders: potential biological determinants.  Horm Behav. 2006;  50 534-538
    CrossrefPubMedGoogle Scholar
  • 3 Angelucci F, Aloe L, Vasquez PJ, Mathe AA. Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression.  Neuroreport. 2000;  11 1369-1373
    PubMedGoogle Scholar
  • 4 Anthony JL, Lonigan CJ, Hooe ES, Phillips BM. An affect-based, hierarchical model of temperament and its relations with internalizing symptomatology.  J Clin Child Adolesc Psychol. 2002;  31 480-490
    PubMedGoogle Scholar
  • 5 Bandelow B, Stein DJ, Dolberg OT, Andersen HF, Baldwin DS. Improvement of quality of life in panic disorder with escitalopram, citalopram, or placebo.  Pharmacopsychiatry. 2007;  40 152-156
    Article in Thieme ConnectPubMedGoogle Scholar
  • 6 Bekker MH, Mens-Verhulst J van. Anxiety disorders: sex differences in prevalence, degree, and background, but gender-neutral treatment.  Gend Med. 2007;  4 S178-S1793
    CrossrefPubMedGoogle Scholar
  • 7 Bimonte-Nelson HA, Nelson ME, Granholm AC. Progesterone counteracts estrogen-induced increases in neurotrophins in the aged female rat brain.  Neuroreport. 2004;  15 2659-2663
    CrossrefPubMedGoogle Scholar
  • 8 Bjorling DE, Beckman M, Clayton MK, Wang ZY. Modulation of nerve growth factor in peripheral organs by estrogen and progesterone.  Neuroscience. 2002;  110 155-167
    CrossrefPubMedGoogle Scholar
  • 9 Calamandrei G, Valanzano A, Ricceri L. NGF induces appearance of adult-like response to spatial novelty in 18-day male mice.  Behav Brain Res. 2002;  136 289-298
    CrossrefPubMedGoogle Scholar
  • 10 Carlbring P, Gustafsson H, Ekselius L, Andersson G. 12-Month prevalence of panic disorder with or without agoraphobia in the Swedish general population.  Soc Psychiatry Psychiatr Epidemiol. 2002;  37 207-211
    CrossrefPubMedGoogle Scholar
  • 11 Caspi A. The child is father of the man: personality continuities from childhood to adulthood.  J Pers Soc Psychol. 2000;  78 158-172
    PubMedGoogle Scholar
  • 12 Davies AM. Neurotrophins: more to NGF than just survival.  Curr Biol. 2000;  10 R374-376
    CrossrefPubMedGoogle Scholar
  • 13 Goldstein JM, Jerram M, Poldrack R, Ahern T, Kennedy DN, Seidman LJ, Makris N. Hormonal cycle modulates arousal circuitry in women using functional magnetic resonance imaging.  J Neurosci. 2005;  9309-9316
    CrossrefPubMedGoogle Scholar
  • 14 Graham P, Stevenson J. Temperament and psychiatric disorder: the genetic contribution to behaviour in childhood.  Aust N Z J Psychiat. 1987;  21 267-274
    PubMedGoogle Scholar
  • 15 Gross C, Hen R. The developmental origins of anxiety.  Nat Rev Neurosci. 2004;  5 545-552
    CrossrefPubMedGoogle Scholar
  • 16 Hasan W, Smith HJ, Ting AY, Smith PG. Estrogen alters trkA and p75 neurotrophin receptor expression within sympathetic neurons.  J Neurobiol. 2005;  65 192-204
    CrossrefPubMedGoogle Scholar
  • 17 Hellweg R, Lang UE, Nagel M, Baumgartner A. Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats.  Mol Psychiat. 2002;  7 604-608
    CrossrefPubMedGoogle Scholar
  • 18 Jockers-Scherubl MC, Zubraegel D, Baer T, Linden M, Danker-Hopfe H, Schulte-Herbruggen O, Neu P, Hellweg R. Nerve growth factor serum concentrations rise after successful cognitive-behavioural therapy of generalized anxiety disorder.  Prog Neuropsychopharmacol Biol Psychiatry. 2007;  31 200-204
    CrossrefPubMedGoogle Scholar
  • 19 Kaur G, Janik J, Isaacson LG, Callahan P. Estrogen regulation of neurotrophin expression in sympathetic neurons and vascular targets.  Brain Res. 2007;  1139 6-14
    CrossrefPubMedGoogle Scholar
  • 20 Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.  Arch Gen Psychiat. 2005;  62 709
    CrossrefPubMedGoogle Scholar
  • 21 Krizsan-Agbas D, Pedchenko T, Hasan W, Smith PG. Oestrogen regulates sympathetic neurite outgrowth by modulating brain derived neurotrophic factor synthesis and release by the rodent uterus.  Eur J Neurosci. 2003;  18 2760-2768
    CrossrefPubMedGoogle Scholar
  • 22 Lang UE, Bajbouj M, Sander T, Gallinat J. Gender-dependent association of the functional catechol-O-methyltransferase Val158Met genotype with sensation seeking personality trait.  Neuropsychopharmacology. 2007;  32 950-955
    PubMedGoogle Scholar
  • 23 Lang UE, Gallinat J, Danker-Hopfe H, Bajbouj M, Hellweg R. Nerve growth factor serum concentrations in healthy human volunteers: physiological variance and stability.  Neurosci Lett. 2003;  344 13-16
    CrossrefPubMedGoogle Scholar
  • 24 Lang UE, Hellweg R, Kalus P, Bajbouj M, Lenzen KP, Sander T, Kunz D, Gallinat J. Association of a functional BDNF polymorphism and anxiety-related personality traits.  Psychopharmacology (Berl). 2005;  180 95-99
    CrossrefPubMedGoogle Scholar
  • 25 Levy F, Hay DA, Bennett KS, MacStephen M. Gender differences in ADHD subtype comorbidity.  J Am Acad Child Adolesc Psychiat. 2005;  44 368-376
    PubMedGoogle Scholar
  • 26 Livak KJ. Allelic discrimination using fluorogenic probes and the 5' nuclease assay.  Genet Anal. 1999;  14 143-149
    PubMedGoogle Scholar
  • 27 Marchesi C, Cantoni A, Fontò S, Giannelli MR, Maggini C. Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study.  Pharmacopsychiatry. 2006;  39 60-65
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Miller SA, Dykes DD, Plesky HF. A simple salting out procedure for extracting DNA from human nucleated cells.  Nucleic Acids Res. 1988;  16 1215
    CrossrefPubMedGoogle Scholar
  • 29 Nam JW, Chung JW, Kho HS, Chung SC, Kim YK. Nerve growth factor concentration in human saliva.  Oral Dis. 2007;  13 187-192
    CrossrefPubMedGoogle Scholar
  • 30 Quinn PO. Treating adolescent girls and women with ADHD: gender-specific issues.  J Clin Psychol. 2005;  61 579-587
    CrossrefPubMedGoogle Scholar
  • 31 Rettew DC, Stanger C, MacKee L, Doyle A, Hudziak JJ. Interactions between child and parent temperament and child behavior problems.  Compr Psychiat. 2006;  47 412-420
    CrossrefPubMedGoogle Scholar
  • 32 Rylett RJ, Williams LR. Role of neurotrophins in cholinergic-neurone function in the adult and aged CNS.  Trends Neurosci. 1994;  17 486-490
    CrossrefPubMedGoogle Scholar
  • 33 Schwartz CE, Snidman N, Kagan J. Adolescent social anxiety as an outcome of inhibited temperament in childhood.  J Am Acad Child Adolesc Psychiat. 1999;  38 1008-1015
    PubMedGoogle Scholar
  • 34 Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.  J Clin Psychiat. 1998;  59 22-33
    Google Scholar
  • 35 Simon NM, Zalta AK, Worthington  JJ 3rd, Hoge EA, Christian KM, Stevens JC, Pollack MH. Preliminary support for gender differences in response to fluoxetine for generalized anxiety disorder.  Depress Anxiety. 2006;  23 373-376
    CrossrefPubMedGoogle Scholar
  • 36 Sloan EK, Capitanio JP, Tarara RP, Cole SW. Social temperament and lymph node innervation.  Brain Behav Immun. 2007;  , Epub
    PubMedGoogle Scholar
  • 37 Spielberger CD. State-Trait Anxiety Inventory: A Comprehensive Bibliography. Palo Alto, Consulting Psychologists Press 1989
  • 38 Syed Z, Dudbridge F, Kent L. An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD.  Am J Med Genet B Neuropsychiatr Genet. 2007;  144 375-378
    PubMedGoogle Scholar
  • 39 Zerssen D von, Akiskal HS. Personality factors in affective disorders: historical developments and current issues with special reference to the concepts of temperament and character.  J Affect Disord. 1998;  51 1-5
    CrossrefPubMedGoogle Scholar
  • 40 Wright LL, Beck C, Perez-Polo JR. Sex differences in nerve growth factor levels in superior cervical ganglia and pineals.  Int J Dev Neurosci. 1987;  5 383-390
    CrossrefPubMedGoogle Scholar
  • 41 Yee BK, Zhu SW, Mohammed AH, Feldon J. Levels of neurotrophic factors in the hippocampus and amygdala correlate with anxiety- and fear-related behaviour in C57BL6 mice.  J Neural Transm. 2006;  114 431-444
    PubMedGoogle Scholar
  • 42 Youngs RM, Chu MS, Meloni EG, Naydenov A, Carlezon  WA Jr, Konradi C. Lithium administration to preadolescent rats causes long-lasting increases in anxiety-like behavior and has molecular consequences.  J Neurosci. 2006;  26 6031-6039
    CrossrefPubMedGoogle Scholar
  • 43 Ziegenhorn AA, Schulte-Herbrüggen O, Danker-Hopfe H, Malbranc M, Hartung HD, Anders D, Lang UE, Steinhagen-Thiessen E, Schaub RT, Hellweg R. Serum neurotrophins − a study on the time course and influencing factors in a large old age sample.  Neurobiol Aging. 2007;  28 1436-1445
    CrossrefPubMedGoogle Scholar
  • 44 Zuluaga MJ, Agrati D, Pereira M, Uriarte N, Fernández-Guasti A, Ferreira A. Experimental anxiety in the black and white model in cycling, pregnant and lactating rats.  Physiol Behav. 2005;  84 279-286
    CrossrefPubMedGoogle Scholar

1 The effect of the ‘gender×genotype’ interaction is also significant after Bonferroni correction (four ANOVAs) with a new significance level of p<0.0125.

Correspondence

U. E. LangMD, PhD 

Clinic for Psychiatry and Psychotherapy

Charité Medicine Berlin

Campus Charité Mitte

10117 Berlin

Germany

Phone: +49/178/624 16 89

Email: undine.lang@charite.de

      >